HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma.

Abstract
The growing epidemic of obesity, which causes nonalcoholic fatty liver disease (NAFLD) and the more severe phenotype nonalcoholic steatohepatitis (NASH), has paralleled the increasing incidence of hepatocellular carcinoma (HCC). Accumulating evidence demonstrates that overnutrition and metabolic pathways can trigger modifications of DNA and histones via deregulation of chromatin modifiers, resulting in aberrant transcriptional activity. However, the epigenetic regulation of HCC development in NAFLD remains obscure. Here, we uncover key epigenetic regulators using both dietary and genetic obesity-promoted HCC models through quantitative expression profiling and characterize the oncogenic activities of histone deacetylase HDAC8 in NAFLD-associated hepatocarcinogenesis. HDAC8 is directly upregulated by the lipogenic transcription factor SREBP-1 where they are coexpressed in dietary obesity models of NASH and HCC. Lentiviral-mediated HDAC8 attenuation in vivo reversed insulin resistance and reduced NAFLD-associated tumorigenicity. HDAC8 modulation by genetic and pharmacologic approaches inhibited p53/p21-mediated apoptosis and G2-M phase cell-cycle arrest and stimulated β-catenin-dependent cell proliferation. Mechanistically, HDAC8 physically interacted with the chromatin modifier EZH2 to concordantly repress Wnt antagonists via histone H4 deacetylation and H3 lysine 27 trimethylation. In human NAFLD-associated HCC, levels of SREBP-1, HDAC8, EZH2, H4 deacetylation, H3K27me3, and active β-catenin were all correlated positively in tumors compared with nontumor tissues. Overall, our findings show how HDAC8 drives NAFLD-associated hepatocarcinogenesis, offering a novel epigenetic target to prevent or treat HCC in obese patients.
AuthorsYuan Tian, Vincent W S Wong, Grace L H Wong, Weiqin Yang, Hanyong Sun, Jiayun Shen, Joanna H M Tong, Minnie Y Y Go, Yue S Cheung, Paul B S Lai, Mingyan Zhou, Gang Xu, Tim H M Huang, Jun Yu, Ka F To, Alfred S L Cheng, Henry L Y Chan
JournalCancer research (Cancer Res) Vol. 75 Issue 22 Pg. 4803-16 (Nov 15 2015) ISSN: 1538-7445 [Electronic] United States
PMID26383163 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2015 American Association for Cancer Research.
Chemical References
  • Repressor Proteins
  • beta Catenin
  • HDAC8 protein, human
  • HDAC8 protein, mouse
  • Histone Deacetylases
Topics
  • Animals
  • Blotting, Western
  • Carcinogenesis (metabolism)
  • Carcinoma, Hepatocellular (enzymology, etiology)
  • Cell Line
  • Chromatin Immunoprecipitation
  • Disease Models, Animal
  • Flow Cytometry
  • Histone Deacetylases (biosynthesis)
  • Humans
  • Immunohistochemistry
  • Insulin Resistance (physiology)
  • Liver Neoplasms (enzymology, etiology)
  • Mice
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease (complications)
  • Obesity (complications)
  • Repressor Proteins (biosynthesis)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcriptome
  • Up-Regulation
  • beta Catenin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: